NCT04183517View on ClinicalTrials.gov

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

April 4, 2020

Study Completion Date

June 24, 2020

Conditions

Pharmacokinetics

Interventions

DRUG

PXS-5382A

Orally once daily or twice daily

Trial Locations (1)

Unknown

CMAX, Adelaide

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Syntara

INDUSTRY